Interesting article: Hope, for those with cancer

[Guest guest]

I saw this article on another forum. I wonder if there is merit in it.

I hope i was not supposed to ask permission to copy it.

 

Cancer Cured For Good

 

By Bill Sardi and Timothy Hubbell

October 2008

 

It works 100% of the time to eradicate cancer completely, and cancer

does not recur even years later. That is how researchers describe the

most convincing cancer cure ever announced.

 

The weekly injection of just 100 billionths of a gram of a harmless

glyco-protein (a naturally-produced molecule with a sugar component

and a protein component) activates the human immune system and cures

cancer for good, according to human studies among breast cancer and

colon cancer patients, producing complete remissions lasting 4 and 7

years respectively. This glyco-protein cure is totally without side

effect but currently goes unused by cancer doctors.

 

Normal Gc protein (also called Vitamin-D binding protein) , an

abundant glyco-protein found in human blood serum, becomes the

molecular switch to activate macrophages when it is converted to its

active form, called Gc macrophage activating factor (Gc-MAF). Gc

protein is normally activated by conversion to Gc-MAF with the help

of the B and T cells (bone marrow-made and thymus gland-made white

blood cells). But, as researchers explain it themselves, cancer cells

secrete an enzyme known as alpha-N-acetylgalactosaminidase (also

called Nagalase) that completely blocks conversion of Gc protein to

Gc-MAF, preventing tumor-cell killing by the macrophages. This is the

way cancer cells escape detection and destruction, by disengaging the

human immune system. This also leaves cancer patients prone to

infections and many then succumb to pneumonia or other infections.

 

The once-weekly injection of minute amounts of Gc-MAF, just 100

nanograms (billionths of a gram), activates macrophages and allows

the immune system to pursue cancer cells with vigor, sufficient to

produce total long-term cures in humans.

 

Nobuto Yamamoto, director of the Division of Cancer Immunology and

Molecular Biology, Socrates Institute for Therapeutic Immunology,

Philadelphia, Pennsylvania, says this is " probably the most potent

macrophage activating factor ever discovered. "

 

Once a sufficient number of activated macrophages are produced,

another Gc-MAF injection is not needed for a week because macrophages

have a half-life of about six days. After 16-22 weekly doses of Gc-

MAF the amount of Nagalase enzyme fell to levels found in healthy

people, which serves as evidence tumors have been completely

eliminated. The treatment was fool-proof - - - it worked in 100% of

16 breast cancer patients and there were no recurrent tumors over a

period of 4 years, says a report in the January 15 issue of the

International Journal of Cancer. [international Journal Cancer.2008

January15; 122(2):461-7]

 

In another startling follow-up report by Dr. Yamamoto and colleagues,

published in the upcoming July issue of Cancer Immunology

Immunotherapy, Gc-MAF therapy totally abolished tumors in 8 colon

cancer patients who had already undergone surgery but still exhibited

circulating cancer cells (metastases). After 32-50 weekly

injections, " all colorectal cancer patients exhibited healthy control

levels of the serum Nagalase activity, indicating eradication of

metastatic tumor cells, " said researchers, an effect that lasted 7

years with no indication of cancer recurrence either by enzyme

activity or CT scans, said researchers. [Cancer Immunology,

Immunotherapy Volume 57, Number 7 / July 2008] Published in an early

online edition of this journal, this confirming report has received

no attention by the new media so far, despite its striking

importance.

 

Gc-MAF treatment for cancer has been agonizingly slow to develop. Dr.

Yamamoto first described this immuno-therapy in 1993. [The Journal of

Immunology, 1993 151 (5); 2794-2802]

 

In a similar animal experiment published in 2003, researchers in

Germany, Japan and the United States collaborated to successfully

demonstrate that after they had injected macrophage activating factor

(Gc-MAF) into tumor-bearing mice, it totally eradicated tumors.

[Neoplasia 2003 January; 5(1): 32�40]

 

In 1997 Dr. Yamamoto injected GcMAF protein into tumor-bearing mice,

with the same startling results. A single enzyme injection doubled

the survival of these mice and just four enzyme injections increased

survival by 6-fold. [Cancer Research 1997 Jun 1; 57(11):2187-92]

 

In 1996 Dr. Yamamoto reported that all 52 cancer patients he had

studied carried elevated blood plasma levels of the immune

inactivating alpha-N-acetylgalactosaminidase enzyme (Nagalase),

whereas healthy humans had very low levels of this enzyme. [Cancer

Research 1996 Jun 15; 56(12):2827-31]

 

In the early 1990s, Dr. Yamamoto first described how the human immune

system is disengaged by enzymes secreted from cancer cells, even

filing a patent on the proposed therapy. [uS Patent 5326749, July

1994; Cancer Research 1996 June 15; 56: 2827-31]

 

Activated Gc protein has been used in humans at much higher doses

without side effect. This Gc macrophage activating factor (Gc-MAF)

has been shown to be effective against a variety of cancers including

breast, prostate, stomach, liver, lung, uterus, ovary, brain, skin,

head/neck cancer, and leukemia.

 

Although GcMAF is also called Vitamin-D binding protein, the

activation of macrophages does not require Vitamin D.

 

It cannot be said the Gc-MAF cancer cure has gone unheralded. Reuters

News covered this developing story in January. But the news story

still did not receive top billing nor did it fully elucidate the

importance of the discovery, actually made years ago, that the human

body is capable of abolishing cancer once its immune system is

properly activated.

 

GcMAF is a naturally made molecule and is not patentable, though its

manufacturing process is patent protected. There is no evidence of

any current effort to commercialize this therapy or put it into

practice. Should such an effective treatment for cancer come into

common practice, the income stream from health-insurance plans for

every oncology office and cancer center in the world Would likely be

reduced to the point of financial insolvency and hundreds of

thousands of jobs would be eliminated.

 

The National Cancer Institute estimates cancer care in the U.S. costs

~$72 billion annually (2004). Furthermore, about $55 billion of

cancer drugs are used annually, none which have not significantly

improved survival rates throughout the history of their use. If a

typical cancer patient had to undergo 30 GcMAF injections at a cost

of $150 per injection, that would cost ~$4500, not counting doctor's

office visits and follow-up testing. For comparison, gene-targeted

cancer drugs range from $13,000 to $100,000 in cost per year and

produce only marginal improvements in survival (weeks to months).

[Targeted Oncology 2007 April, 2 (2); 113-19]

 

Up to this point, the National Cancer Institute is totally silent on

this discovery and there is no evidence the cancer care industry

plans to quickly mobilize to use this otherwise harmless treatment.

 

- -

 

Based in Southern California, Bill Sardi is a notedand well-known

author, lecturer, speaker, and health researcher, with numerous books

and articles to his credit. He can be reached at BSardi.

Timothy Hubbell, a biochemist from Cincinnati, first called attention

to this discovery and provided consultation on the biochemistry.

[Guest guest]

On 11/20/2008, marmeyh (Martie.Hanekom) wrote:

> I saw this article on another forum. I wonder if there is merit in it.

> I hope i was not supposed to ask permission to copy it.

 

Technically, yes, you are supposed to get permission before posting full

articles like this, unless the authors explicitly grant permission to

repost freely without permission...

 

At a bare minimum, you should always post the full link to the original

article - and I would be very interested in that link...

[Guest guest]

On 11/20/2008, Simon (tanstaafl) wrote:

> At a bare minimum, you should always post the full link to the original

> article - and I would be very interested in that link...

 

Well, here is one:

 

http://www.thenhf.com/articles/articles_792/articles_792.htm

[Guest guest]

I am relatively skeptical about articles like this one which claim a final cure for cancer. Firstly, the researchers often use markers that are claimed to show that the cancer has been cured. Whether these markers in fact show any such thing, must be shown. Secondly, as in the case of Hulda Clark, some researchers maintain that their test subjects have cancer according to their own definitions and/or markers and then, when these markers show improvement, they claim a cure. Thirdly, many researchers do their tests in a test tube but then fail to duplicate the results on real people. Lastly and most importantly, many people (myself included) believe that cancer is a self-protection mechanism when body cells are being threatened by an imbalance in our inner terrain. The threatened cells then convert from the normal cell-division process of oxidation to the archaic cell-division method of fermentation, a process mediated by a switch mechanism in the mitochondria. This is what Otto Warburg received his Nobel prize for although he did not know about the mitochondrial involvement. Dr Heinrich Kremer of Germany has written a whole book about this (Unfortunately, it is in German and the available translations of one or two chapters are not very good). Cancer cells are thus NOT deemed foreign cells and that is why they are not recognized by our immune systems. According to the oxidation/fermentation theory which view cancer as but a symptom of underlying problems in the body, a process that relies on immune system activation is not viable unless it addresses the inner terrain problem at the same time.

 

Marc Swanepoel

 

 

-

Simon

oleander soup

Thursday, November 20, 2008 4:05 PM

Re: Interesting article: Hope, for those with cancer

 

 

On 11/20/2008, Simon (tanstaafl (AT) libertytrek (DOT) org) wrote:> At a bare minimum, you should always post the full link to the original> article - and I would be very interested in that link...Well, here is one:http://www.thenhf.com/articles/articles_792/articles_792.htm

[Guest guest]

I know for a fact that the article is true. Unfortunately Dr. Yamamoto needs funding which are not available. He is swimming against the current trying to safe lifes.marmeyh <Martie.Hanekomoleander soup Sent: Thursday, November 20, 2008 8:53:27 AM Interesting article: Hope, for those with cancer

 

I saw this article on another forum. I wonder if there is merit in it.

I hope i was not supposed to ask permission to copy it.

 

Cancer Cured For Good

 

By Bill Sardi and Timothy Hubbell

October 2008

 

It works 100% of the time to eradicate cancer completely, and cancer

does not recur even years later. That is how researchers describe the

most convincing cancer cure ever announced.

 

The weekly injection of just 100 billionths of a gram of a harmless

glyco-protein (a naturally-produced molecule with a sugar component

and a protein component) activates the human immune system and cures

cancer for good, according to human studies among breast cancer and

colon cancer patients, producing complete remissions lasting 4 and 7

years respectively. This glyco-protein cure is totally without side

effect but currently goes unused by cancer doctors.

 

Normal Gc protein (also called Vitamin-D binding protein) , an

abundant glyco-protein found in human blood serum, becomes the

molecular switch to activate macrophages when it is converted to its

active form, called Gc macrophage activating factor (Gc-MAF). Gc

protein is normally activated by conversion to Gc-MAF with the help

of the B and T cells (bone marrow-made and thymus gland-made white

blood cells). But, as researchers explain it themselves, cancer cells

secrete an enzyme known as alpha-N-acetylgalac tosaminidase (also

called Nagalase) that completely blocks conversion of Gc protein to

Gc-MAF, preventing tumor-cell killing by the macrophages. This is the

way cancer cells escape detection and destruction, by disengaging the

human immune system. This also leaves cancer patients prone to

infections and many then succumb to pneumonia or other infections.

 

The once-weekly injection of minute amounts of Gc-MAF, just 100

nanograms (billionths of a gram), activates macrophages and allows

the immune system to pursue cancer cells with vigor, sufficient to

produce total long-term cures in humans.

 

Nobuto Yamamoto, director of the Division of Cancer Immunology and

Molecular Biology, Socrates Institute for Therapeutic Immunology,

Philadelphia, Pennsylvania, says this is "probably the most potent

macrophage activating factor ever discovered."

 

Once a sufficient number of activated macrophages are produced,

another Gc-MAF injection is not needed for a week because macrophages

have a half-life of about six days. After 16-22 weekly doses of Gc-

MAF the amount of Nagalase enzyme fell to levels found in healthy

people, which serves as evidence tumors have been completely

eliminated. The treatment was fool-proof - - - it worked in 100% of

16 breast cancer patients and there were no recurrent tumors over a

period of 4 years, says a report in the January 15 issue of the

International Journal of Cancer. [international Journal Cancer.2008

January15; 122(2):461-7]

 

In another startling follow-up report by Dr. Yamamoto and colleagues,

published in the upcoming July issue of Cancer Immunology

Immunotherapy, Gc-MAF therapy totally abolished tumors in 8 colon

cancer patients who had already undergone surgery but still exhibited

circulating cancer cells (metastases) . After 32-50 weekly

injections, "all colorectal cancer patients exhibited healthy control

levels of the serum Nagalase activity, indicating eradication of

metastatic tumor cells,"said researchers, an effect that lasted 7

years with no indication of cancer recurrence either by enzyme

activity or CT scans, said researchers. [Cancer Immunology,

Immunotherapy Volume 57, Number 7 / July 2008] Published in an early

online edition of this journal, this confirming report has received

no attention by the new media so far, despite its striking

importance.

 

Gc-MAF treatment for cancer has been agonizingly slow to develop. Dr.

Yamamoto first described this immuno-therapy in 1993. [The Journal of

Immunology, 1993 151 (5); 2794-2802]

 

In a similar animal experiment published in 2003, researchers in

Germany, Japan and the United States collaborated to successfully

demonstrate that after they had injected macrophage activating factor

(Gc-MAF) into tumor-bearing mice, it totally eradicated tumors.

[Neoplasia 2003 January; 5(1): 32�40]

 

In 1997 Dr. Yamamoto injected GcMAF protein into tumor-bearing mice,

with the same startling results. A single enzyme injection doubled

the survival of these mice and just four enzyme injections increased

survival by 6-fold. [Cancer Research 1997 Jun 1; 57(11):2187- 92]

 

In 1996 Dr. Yamamoto reported that all 52 cancer patients he had

studied carried elevated blood plasma levels of the immune

inactivating alpha-N-acetylgalac tosaminidase enzyme (Nagalase),

whereas healthy humans had very low levels of this enzyme. [Cancer

Research 1996 Jun 15; 56(12):2827- 31]

 

In the early 1990s, Dr. Yamamoto first described how the human immune

system is disengaged by enzymes secreted from cancer cells, even

filing a patent on the proposed therapy. [uS Patent 5326749, July

1994; Cancer Research 1996 June 15; 56: 2827-31]

 

Activated Gc protein has been used in humans at much higher doses

without side effect. This Gc macrophage activating factor (Gc-MAF)

has been shown to be effective against a variety of cancers including

breast, prostate, stomach, liver, lung, uterus, ovary, brain, skin,

head/neck cancer, and leukemia.

 

Although GcMAF is also called Vitamin-D binding protein, the

activation of macrophages does not require Vitamin D.

 

It cannot be said the Gc-MAF cancer cure has gone unheralded. Reuters

News covered this developing story in January. But the news story

still did not receive top billing nor did it fully elucidate the

importance of the discovery, actually made years ago, that the human

body is capable of abolishing cancer once its immune system is

properly activated.

 

GcMAF is a naturally made molecule and is not patentable, though its

manufacturing process is patent protected. There is no evidence of

any current effort to commercialize this therapy or put it into

practice. Should such an effective treatment for cancer come into

common practice, the income stream from health-insurance plans for

every oncology office and cancer center in the world Would likely be

reduced to the point of financial insolvency and hundreds of

thousands of jobs would be eliminated.

 

The National Cancer Institute estimates cancer care in the U.S. costs

~$72 billion annually (2004). Furthermore, about $55 billion of

cancer drugs are used annually, none which have not significantly

improved survival rates throughout the history of their use. If a

typical cancer patient had to undergo 30 GcMAF injections at a cost

of $150 per injection, that would cost ~$4500, not counting doctor's

office visits and follow-up testing. For comparison, gene-targeted

cancer drugs range from $13,000 to $100,000 in cost per year and

produce only marginal improvements in survival (weeks to months).

[Targeted Oncology 2007 April, 2 (2); 113-19]

 

Up to this point, the National Cancer Institute is totally silent on

this discovery and there is no evidence the cancer care industry

plans to quickly mobilize to use this otherwise harmless treatment.

 

- -

 

Based in Southern California, Bill Sardi is a notedand well-known

author, lecturer, speaker, and health researcher, with numerous books

and articles to his credit. He can be reached at BSardi.

Timothy Hubbell, a biochemist from Cincinnati, first called attention

to this discovery and provided consultation on the biochemistry.

[Guest guest]

Dr. Yamamoto has published several papers dating back to 1990's and cured over 100 in Japan. Unfortunately no one cares, because as we know there is a lot of money for the health industry in oncology. I do hope and pray that someone pays attention.MaritzaMarc Swanepoel - PhD <marcswanoleander soup Sent: Thursday, November 20, 2008 9:41:02 AMRe: Interesting article: Hope, for those with cancer

 

 

I am relatively skeptical about articles like this one which claim a final cure for cancer. Firstly, the researchers often use markers that are claimed to show that the cancer has been cured. Whether these markers in fact show any such thing, must be shown. Secondly, as in the case of Hulda Clark, some researchers maintain that their test subjects have cancer according to their own definitions and/or markers and then, when these markers show improvement, they claim a cure. Thirdly, many researchers do their tests in a test tube but then fail to duplicate the results on real people. Lastly and most importantly, many people (myself included) believe that cancer is a self-protection mechanism when body cells are being threatened by an imbalance in our inner terrain. The threatened cells then convert from the normal cell-division process of oxidation to the archaic cell-division method of fermentation, a process mediated by a switch mechanism in the mitochondria. This is what Otto Warburg received his Nobel prize for although he did not know about the mitochondrial involvement. Dr Heinrich Kremer of Germany has written a whole book about this (Unfortunately, it is in German and the available translations of one or two chapters are not very good). Cancer cells are thus NOT deemed foreign cells and that is why they are not recognized by our immune systems. According to the oxidation/fermentat ion theory which view cancer as but a symptom of underlying problems in the body, a process that relies on immune system activation is not viable unless it addresses the inner terrain problem at the same time.

 

Marc Swanepoel

 

 

-

Simon

oleander soup

Thursday, November 20, 2008 4:05 PM

Re: Interesting article: Hope, for those with cancer

 

 

On 11/20/2008, Simon (tanstaafl@libertytr ek.org) wrote:> At a bare minimum, you should always post the full link to the original> article - and I would be very interested in that link...Well, here is one:http://www.thenhf. com/articles/ articles_ 792/articles_ 792.htm

[Guest guest]

Hi Marc,

You are on the same thought train it sounds as Andreas Mortiz, he wrote the book "Cancer is not a Disease it is a Survival Mechanism". Wonderful book, I'm sure you have heard of or read. I recently read it and enjoyed it. A must read for anyone who has or had cancer.

 

Tammatha

 

-

Marc Swanepoel - PhD

oleander soup

Thursday, November 20, 2008 6:41 AM

Re: Interesting article: Hope, for those with cancer

 

 

 

I am relatively skeptical about articles like this one which claim a final cure for cancer. Firstly, the researchers often use markers that are claimed to show that the cancer has been cured. Whether these markers in fact show any such thing, must be shown. Secondly, as in the case of Hulda Clark, some researchers maintain that their test subjects have cancer according to their own definitions and/or markers and then, when these markers show improvement, they claim a cure. Thirdly, many researchers do their tests in a test tube but then fail to duplicate the results on real people. Lastly and most importantly, many people (myself included) believe that cancer is a self-protection mechanism when body cells are being threatened by an imbalance in our inner terrain. The threatened cells then convert from the normal cell-division process of oxidation to the archaic cell-division method of fermentation, a process mediated by a switch mechanism in the mitochondria. This is what Otto Warburg received his Nobel prize for although he did not know about the mitochondrial involvement. Dr Heinrich Kremer of Germany has written a whole book about this (Unfortunately, it is in German and the available translations of one or two chapters are not very good). Cancer cells are thus NOT deemed foreign cells and that is why they are not recognized by our immune systems. According to the oxidation/fermentation theory which view cancer as but a symptom of underlying problems in the body, a process that relies on immune system activation is not viable unless it addresses the inner terrain problem at the same time.

 

Marc Swanepoel

 

 

-

Simon

oleander soup

Thursday, November 20, 2008 4:05 PM

Re: Interesting article: Hope, for those with cancer

 

 

On 11/20/2008, Simon (tanstaafl (AT) libertytrek (DOT) org) wrote:> At a bare minimum, you should always post the full link to the original> article - and I would be very interested in that link...Well, here is one:http://www.thenhf.com/articles/articles_792/articles_792.htm

[Guest guest]

On 11/20/2008 10:56 AM, Maritza Vlasaty wrote:

> I know for a fact that the article is true. Unfortunately Dr. Yamamoto

> needs funding which are not available. He is swimming against the

> current trying to safe lifes.

 

Are you sure? From the link I posted (at the very bottom):

 

" Addendum: Sadly, the treatment you have just read about is not

available anywhere. Its inventor is attempting to patent a version of it

to profiteer off of it even though there is no need to improve upon the

GcMAF molecule - - it worked without failure to completely cure four

different types of cancer with no long-term remissions and without side

effect. While GcMAF is produced by every healthy adult, there are no

centers available to extract it from blood samples and inject it into

patients with malignancies. Hopefully, someday, doctors will write

protocols to do this and submit them to institutional review boards so

GcMAF treatment can be performed on an experimental basis. GcMAF is a

naturally-made molecule that cannot be patented. This article was

written to reveal that there are proven cancer cures that go unused. Of

interest, not one oncologist has requested information about GcMAF since

this article was written, while I have been barraged with inquires from

cancer patients, their families and some interested physicians who are

not cancer doctors.

-Bill Sardi "

[Guest guest]

On 11/20/2008, Marc Swanepoel - PhD (marcswan) wrote:

> According to the oxidation/fermentation theory which view cancer as

> but a symptom of underlying problems in the body, a process that

> relies on immune system activation is not viable unless it addresses

> the inner terrain problem at the same time.

 

Here, here! (he said as he downed another pint)

 

I also believe that this applies to pretty much *all* disease, not just

cancer.

[Guest guest]

Yes, I am sure. He is trying to make it profitable to gain interest from the pharmaceutical companies. Unfortunately I am not at liberty to reveal my source. He is a humble man going against the wind.MaritzaSimon <tanstaafloleander soup Sent: Thursday, November 20, 2008 12:32:41

PMRe: Interesting article: Hope, for those with cancer

 

On 11/20/2008 10:56 AM, Maritza Vlasaty wrote:

> I know for a fact that the article is true. Unfortunately Dr. Yamamoto

> needs funding which are not available. He is swimming against the

> current trying to safe lifes.

 

Are you sure? From the link I posted (at the very bottom):

 

"Addendum: Sadly, the treatment you have just read about is not

available anywhere. Its inventor is attempting to patent a version of it

to profiteer off of it even though there is no need to improve upon the

GcMAF molecule - - it worked without failure to completely cure four

different types of cancer with no long-term remissions and without side

effect. While GcMAF is produced by every healthy adult, there are no

centers available to extract it from blood samples and inject it into

patients with malignancies. Hopefully, someday, doctors will write

protocols to do this and submit them to institutional review boards so

GcMAF treatment can be performed on an experimental basis. GcMAF is a

naturally-made molecule that cannot be patented. This article was

written to reveal that there are proven cancer cures that go unused. Of

interest, not one oncologist has requested information about GcMAF since

this article was written, while I have been barraged with inquires from

cancer patients, their families and some interested physicians who are

not cancer doctors.

-Bill Sardi"

[Guest guest]

On 11/20/2008 1:09 PM, Maritza Vlasaty wrote:

> Yes, I am sure. He is trying to make it profitable to gain interest from

> the pharmaceutical companies.

 

Excuse me for not having my rose colored glasses on, but... if he were

truly interested in making this available to help heal people, the best

way is to simply publish to the public domain *all* of his information,

including how to make the stuff.

 

> Unfortunately I am not at liberty to reveal my source.

 

Um... unfortunately, I am not at liberty to accept claims based on

secret evidence.

 

> He is a humble man going against the wind.

 

Maybe - but the evidence at hand doesn't support such a conclusion...

 

> ------

> ** Simon <tanstaafl

> *To:* oleander soup

> *Sent:* Thursday, November 20, 2008 12:32:41 PM

> *Subject:* Re: Interesting article: Hope, for those with

> cancer

>

> On 11/20/2008 10:56 AM, Maritza Vlasaty wrote:

>> I know for a fact that the article is true. Unfortunately Dr. Yamamoto

>> needs funding which are not available. He is swimming against the

>> current trying to safe lifes.

>

> Are you sure? From the link I posted (at the very bottom):

>

> " Addendum: Sadly, the treatment you have just read about is not

> available anywhere. Its inventor is attempting to patent a version of it

> to profiteer off of it even though there is no need to improve upon the

> GcMAF molecule - - it worked without failure to completely cure four

> different types of cancer with no long-term remissions and without side

> effect. While GcMAF is produced by every healthy adult, there are no

> centers available to extract it from blood samples and inject it into

> patients with malignancies. Hopefully, someday, doctors will write

> protocols to do this and submit them to institutional review boards so

> GcMAF treatment can be performed on an experimental basis. GcMAF is a

> naturally-made molecule that cannot be patented. This article was

> written to reveal that there are proven cancer cures that go unused. Of

> interest, not one oncologist has requested information about GcMAF since

> this article was written, while I have been barraged with inquires from

> cancer patients, their families and some interested physicians who are

> not cancer doctors.

> -Bill Sardi "

[Guest guest]

I have read all Moritz's books including the one on cancer as a symptom. He has some very interesting points.

Marc S

 

-

Tammatha

oleander soup

Thursday, November 20, 2008 7:31 PM

Re: Interesting article: Hope, for those with cancer

 

 

 

Hi Marc,

You are on the same thought train it sounds as Andreas Mortiz, he wrote the book "Cancer is not a Disease it is a Survival Mechanism". Wonderful book, I'm sure you have heard of or read. I recently read it and enjoyed it. A must read for anyone who has or had cancer.

 

Tammatha

 

-

Marc Swanepoel - PhD

oleander soup

Thursday, November 20, 2008 6:41 AM

Re: Interesting article: Hope, for those with cancer

 

 

 

I am relatively skeptical about articles like this one which claim a final cure for cancer. Firstly, the researchers often use markers that are claimed to show that the cancer has been cured. Whether these markers in fact show any such thing, must be shown. Secondly, as in the case of Hulda Clark, some researchers maintain that their test subjects have cancer according to their own definitions and/or markers and then, when these markers show improvement, they claim a cure. Thirdly, many researchers do their tests in a test tube but then fail to duplicate the results on real people. Lastly and most importantly, many people (myself included) believe that cancer is a self-protection mechanism when body cells are being threatened by an imbalance in our inner terrain. The threatened cells then convert from the normal cell-division process of oxidation to the archaic cell-division method of fermentation, a process mediated by a switch mechanism in the mitochondria. This is what Otto Warburg received his Nobel prize for although he did not know about the mitochondrial involvement. Dr Heinrich Kremer of Germany has written a whole book about this (Unfortunately, it is in German and the available translations of one or two chapters are not very good). Cancer cells are thus NOT deemed foreign cells and that is why they are not recognized by our immune systems. According to the oxidation/fermentation theory which view cancer as but a symptom of underlying problems in the body, a process that relies on immune system activation is not viable unless it addresses the inner terrain problem at the same time.

 

Marc Swanepoel

 

 

-

Simon

oleander soup

Thursday, November 20, 2008 4:05 PM

Re: Interesting article: Hope, for those with cancer

 

 

On 11/20/2008, Simon (tanstaafl (AT) libertytrek (DOT) org) wrote:> At a bare minimum, you should always post the full link to the original> article - and I would be very interested in that link...Well, here is one:http://www.thenhf.com/articles/articles_792/articles_792.htm

[Guest guest]

I understand. Everyone is entitled to their opinion. Simon <tanstaafloleander soup Sent: Thursday, November 20, 2008 1:14:32 PMRe: Interesting article: Hope, for those with cancer

 

On 11/20/2008 1:09 PM, Maritza Vlasaty wrote:

> Yes, I am sure. He is trying to make it profitable to gain interest from

> the pharmaceutical companies.

 

Excuse me for not having my rose colored glasses on, but... if he were

truly interested in making this available to help heal people, the best

way is to simply publish to the public domain *all* of his information,

including how to make the stuff.

 

> Unfortunately I am not at liberty to reveal my source.

 

Um... unfortunately, I am not at liberty to accept claims based on

secret evidence.

 

> He is a humble man going against the wind.

 

Maybe - but the evidence at hand doesn't support such a conclusion.. .

 

> ------------ --------- --------- --------- --------- --------- -

> ** Simon <tanstaafl@libertytr ek.org>

> *To:* oleander soup

> *Sent:* Thursday, November 20, 2008 12:32:41 PM

> *Subject:* Re: Interesting article: Hope, for those with

> cancer

>

> On 11/20/2008 10:56 AM, Maritza Vlasaty wrote:

>> I know for a fact that the article is true. Unfortunately Dr. Yamamoto

>> needs funding which are not available. He is swimming against the

>> current trying to safe lifes.

>

> Are you sure? From the link I posted (at the very bottom):

>

> "Addendum: Sadly, the treatment you have just read about is not

> available anywhere. Its inventor is attempting to patent a version of it

> to profiteer off of it even though there is no need to improve upon the

> GcMAF molecule - - it worked without failure to completely cure four

> different types of cancer with no long-term remissions and without side

> effect. While GcMAF is produced by every healthy adult, there are no

> centers available to extract it from blood samples and inject it into

> patients with malignancies. Hopefully, someday, doctors will write

> protocols to do this and submit them to institutional review boards so

> GcMAF treatment can be performed on an experimental basis. GcMAF is a

> naturally-made molecule that cannot be patented. This article was

> written to reveal that there are proven cancer cures that go unused. Of

> interest, not one oncologist has requested information about GcMAF since

> this article was written, while I have been barraged with inquires from

> cancer patients, their families and some interested physicians who are

> not cancer doctors.

> -Bill Sardi"

[Guest guest]

After digging into this all day, here is the product that they have made available that Bill Sardi is somehow a part of:

http://www.longevinex.com/

 

Hugs,

Rose www.orangecountypropertyservices.com714.549-3519 Office/Fax 714.349-1200 Cell

Be who you are and say what you feel, because those who mind don't matter and those who matter don't mind. ~Dr. Seuss

 

oleander soup From: tanstaaflDate: Thu, 20 Nov 2008 13:14:32 -0500Re: Interesting article: Hope, for those with cancer

 

 

 

On 11/20/2008 1:09 PM, Maritza Vlasaty wrote:> Yes, I am sure. He is trying to make it profitable to gain interest from> the pharmaceutical companies.Excuse me for not having my rose colored glasses on, but... if he weretruly interested in making this available to help heal people, the bestway is to simply publish to the public domain *all* of his information,including how to make the stuff.> Unfortunately I am not at liberty to reveal my source.Um... unfortunately, I am not at liberty to accept claims based onsecret evidence.> He is a humble man going against the wind.Maybe - but the evidence at hand doesn't support such a conclusion...> -------------------------> ** Simon <tanstaafl (AT) libertytrek (DOT) org>> *To:* oleander soup > *Sent:* Thursday, November 20, 2008 12:32:41 PM> *Subject:* Re: Interesting article: Hope, for those with> cancer> > On 11/20/2008 10:56 AM, Maritza Vlasaty wrote:>> I know for a fact that the article is true. Unfortunately Dr. Yamamoto>> needs funding which are not available. He is swimming against the>> current trying to safe lifes.> > Are you sure? From the link I posted (at the very bottom):> > "Addendum: Sadly, the treatment you have just read about is not> available anywhere. Its inventor is attempting to patent a version of it> to profiteer off of it even though there is no need to improve upon the> GcMAF molecule - - it worked without failure to completely cure four> different types of cancer with no long-term remissions and without side> effect. While GcMAF is produced by every healthy adult, there are no> centers available to extract it from blood samples and inject it into> patients with malignancies. Hopefully, someday, doctors will write> protocols to do this and submit them to institutional review boards so> GcMAF treatment can be performed on an experimental basis. GcMAF is a> naturally-made molecule that cannot be patented. This article was> written to reveal that there are proven cancer cures that go unused. Of> interest, not one oncologist has requested information about GcMAF since> this article was written, while I have been barraged with inquires from> cancer patients, their families and some interested physicians who are> not cancer doctors.> -Bill Sardi" Windows Live Hotmail now works up to 70% faster. Sign up today.

[Guest guest]

I posted another article by Bill Sardi on another site quite some time

ago and just got an email yesterday from the site manager that he had

been contacted by Mr. Sardi who asked him to take the article off. He

didn't even want a link to the article.

 

I understand that Mr. Sardi now has a new book out entitled You Don't

Have to Be Afraid of Cancer Anymore. He may be sensitive to attacks by

the FDA and pharmafia and a bit paranoid as a result, but why post at

all if that's the case? Just doing a search on his name produces links

to his articles.

 

oleander soup , " marmeyh " <Martie.Hanekom wrote:

>

> I saw this article on another forum. I wonder if there is merit in it.

> I hope i was not supposed to ask permission to copy it.

>

> Cancer Cured For Good

>

> By Bill Sardi and Timothy Hubbell

> October 2008

>

> It works 100% of the time to eradicate cancer completely, and cancer

> does not recur even years later. That is how researchers describe the

> most convincing cancer cure ever announced.

>

> The weekly injection of just 100 billionths of a gram of a harmless

> glyco-protein (a naturally-produced molecule with a sugar component

> and a protein component) activates the human immune system and cures

> cancer for good, according to human studies among breast cancer and

> colon cancer patients, producing complete remissions lasting 4 and 7

> years respectively. This glyco-protein cure is totally without side

> effect but currently goes unused by cancer doctors.

>

> Normal Gc protein (also called Vitamin-D binding protein) , an

> abundant glyco-protein found in human blood serum, becomes the

> molecular switch to activate macrophages when it is converted to its

> active form, called Gc macrophage activating factor (Gc-MAF). Gc

> protein is normally activated by conversion to Gc-MAF with the help

> of the B and T cells (bone marrow-made and thymus gland-made white

> blood cells). But, as researchers explain it themselves, cancer cells

> secrete an enzyme known as alpha-N-acetylgalactosaminidase (also

> called Nagalase) that completely blocks conversion of Gc protein to

> Gc-MAF, preventing tumor-cell killing by the macrophages. This is the

> way cancer cells escape detection and destruction, by disengaging the

> human immune system. This also leaves cancer patients prone to

> infections and many then succumb to pneumonia or other infections.

>

> The once-weekly injection of minute amounts of Gc-MAF, just 100

> nanograms (billionths of a gram), activates macrophages and allows

> the immune system to pursue cancer cells with vigor, sufficient to

> produce total long-term cures in humans.

>

> Nobuto Yamamoto, director of the Division of Cancer Immunology and

> Molecular Biology, Socrates Institute for Therapeutic Immunology,

> Philadelphia, Pennsylvania, says this is " probably the most potent

> macrophage activating factor ever discovered. "

>

> Once a sufficient number of activated macrophages are produced,

> another Gc-MAF injection is not needed for a week because macrophages

> have a half-life of about six days. After 16-22 weekly doses of Gc-

> MAF the amount of Nagalase enzyme fell to levels found in healthy

> people, which serves as evidence tumors have been completely

> eliminated. The treatment was fool-proof - - - it worked in 100% of

> 16 breast cancer patients and there were no recurrent tumors over a

> period of 4 years, says a report in the January 15 issue of the

> International Journal of Cancer. [international Journal Cancer.2008

> January15; 122(2):461-7]

>

> In another startling follow-up report by Dr. Yamamoto and colleagues,

> published in the upcoming July issue of Cancer Immunology

> Immunotherapy, Gc-MAF therapy totally abolished tumors in 8 colon

> cancer patients who had already undergone surgery but still exhibited

> circulating cancer cells (metastases). After 32-50 weekly

> injections, " all colorectal cancer patients exhibited healthy control

> levels of the serum Nagalase activity, indicating eradication of

> metastatic tumor cells, " said researchers, an effect that lasted 7

> years with no indication of cancer recurrence either by enzyme

> activity or CT scans, said researchers. [Cancer Immunology,

> Immunotherapy Volume 57, Number 7 / July 2008] Published in an early

> online edition of this journal, this confirming report has received

> no attention by the new media so far, despite its striking

> importance.

>

> Gc-MAF treatment for cancer has been agonizingly slow to develop. Dr.

> Yamamoto first described this immuno-therapy in 1993. [The Journal of

> Immunology, 1993 151 (5); 2794-2802]

>

> In a similar animal experiment published in 2003, researchers in

> Germany, Japan and the United States collaborated to successfully

> demonstrate that after they had injected macrophage activating factor

> (Gc-MAF) into tumor-bearing mice, it totally eradicated tumors.

> [Neoplasia 2003 January; 5(1): 32�40]

>

> In 1997 Dr. Yamamoto injected GcMAF protein into tumor-bearing mice,

> with the same startling results. A single enzyme injection doubled

> the survival of these mice and just four enzyme injections increased

> survival by 6-fold. [Cancer Research 1997 Jun 1; 57(11):2187-92]

>

> In 1996 Dr. Yamamoto reported that all 52 cancer patients he had

> studied carried elevated blood plasma levels of the immune

> inactivating alpha-N-acetylgalactosaminidase enzyme (Nagalase),

> whereas healthy humans had very low levels of this enzyme. [Cancer

> Research 1996 Jun 15; 56(12):2827-31]

>

> In the early 1990s, Dr. Yamamoto first described how the human immune

> system is disengaged by enzymes secreted from cancer cells, even

> filing a patent on the proposed therapy. [uS Patent 5326749, July

> 1994; Cancer Research 1996 June 15; 56: 2827-31]

>

> Activated Gc protein has been used in humans at much higher doses

> without side effect. This Gc macrophage activating factor (Gc-MAF)

> has been shown to be effective against a variety of cancers including

> breast, prostate, stomach, liver, lung, uterus, ovary, brain, skin,

> head/neck cancer, and leukemia.

>

> Although GcMAF is also called Vitamin-D binding protein, the

> activation of macrophages does not require Vitamin D.

>

> It cannot be said the Gc-MAF cancer cure has gone unheralded. Reuters

> News covered this developing story in January. But the news story

> still did not receive top billing nor did it fully elucidate the

> importance of the discovery, actually made years ago, that the human

> body is capable of abolishing cancer once its immune system is

> properly activated.

>

> GcMAF is a naturally made molecule and is not patentable, though its

> manufacturing process is patent protected. There is no evidence of

> any current effort to commercialize this therapy or put it into

> practice. Should such an effective treatment for cancer come into

> common practice, the income stream from health-insurance plans for

> every oncology office and cancer center in the world Would likely be

> reduced to the point of financial insolvency and hundreds of

> thousands of jobs would be eliminated.

>

> The National Cancer Institute estimates cancer care in the U.S. costs

> ~$72 billion annually (2004). Furthermore, about $55 billion of

> cancer drugs are used annually, none which have not significantly

> improved survival rates throughout the history of their use. If a

> typical cancer patient had to undergo 30 GcMAF injections at a cost

> of $150 per injection, that would cost ~$4500, not counting doctor's

> office visits and follow-up testing. For comparison, gene-targeted

> cancer drugs range from $13,000 to $100,000 in cost per year and

> produce only marginal improvements in survival (weeks to months).

> [Targeted Oncology 2007 April, 2 (2); 113-19]

>

> Up to this point, the National Cancer Institute is totally silent on

> this discovery and there is no evidence the cancer care industry

> plans to quickly mobilize to use this otherwise harmless treatment.

>

> - -

>

> Based in Southern California, Bill Sardi is a notedand well-known

> author, lecturer, speaker, and health researcher, with numerous books

> and articles to his credit. He can be reached at BSardi

> Timothy Hubbell, a biochemist from Cincinnati, first called attention

> to this discovery and provided consultation on the biochemistry.

>